PHARMANUTRA PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR Stock: price and directors' dealings · Italy · Consob

Follow the PHARMANUTRA PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR stock price and the full insider trade history of the company, a listed equity based in Italy. Shares are listed on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA - PHN - ORIENTAMENTI DEL CDA AGLI AZIONISTI SULLA FUTURA DIMENSIONE E COMPOSIZIONE DEL NUOVO CDA - NOMINA DELL’INVESTOR RELATOR has logged 0 public disclosures. Market capitalisation: €787.1m. Every trade is openly available.